Arkolith/Insider Trading/EBS/Form 4

Hartzel William

SVP, BioservicesEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed Feb 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Disposed to issuer(D)6K$10.92$63K97K
Feb 6, 2026Tax withholding(F)630$10.92$7K97K

Transaction Codes

D
Disposition to the issuer
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001989644-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML